• Enact Holdings reported first-quarter 2026 results that beat consensus earnings expectations but came with higher-than-anticipated losses and a flat revenue outlook, while EVP & COO Brian Gould sold 23,000 shares of company stock on June 1, 2026.
• The combination of stagnant net premiums over five years, muted sales projections, and insider selling has sharpened investor focus on whether Enact’s growth and capital-return story can keep compensating for demand headwinds.
• Now we’ll examine how concerns over flat premium growth and demand challenges may reshape Enact Holdings’ investment narrative centered on capital returns.

This technology could replace computers: discover 30 stocks that are working to make quantum computing a reality.

Enact Holdings Investment Narrative Recap

To own Enact, you need to believe its mortgage insurance franchise and capital return program can offset sluggish premium growth and demand headwinds. The latest earnings beat, paired with higher losses and flat sales expectations, does not appear to materially change the near term focus on how well Enact manages loss ratios and sustains capital returns as its most important catalyst and key risk.

The most relevant recent announcement is Enact’s ongoing share repurchase activity under its agreement with Genworth Financial, including US$60.29 million in buybacks in the first quarter of 2026. That continued capital return, alongside a higher quarterly dividend of US$0.24 per share, frames how management is responding to muted growth expectations and may influence how investors weigh near term catalysts against demand concerns.

Yet behind the steady buybacks and dividends, investors should be aware of the risk that a persistently flat mortgage insurance market could...

Enact Holdings' narrative projects $1.3 billion revenue and $681.6 million earnings by 2029. This requires 2.0% yearly revenue growth and a $5.4 million earnings increase from $676.2 million today.

Uncover how Enact Holdings' forecasts yield a $45.75 fair value, a 9% upside to its current price.

Exploring Other Perspectives

One member of the Simply Wall St Community values Enact at US$85.25 per share, far above the recent market price. Others may weigh this against the risk that a flat mortgage insurance market could limit revenue growth, so it is worth comparing several viewpoints before deciding how that might influence Enact’s longer term performance.

Explore another fair value estimate on Enact Holdings - why the stock might be worth just $85.25!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Enact Holdings research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Enact Holdings research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Enact Holdings' overall financial health at a glance.

Seeking Other Investments?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 13 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Capitalize on the AI infrastructure supercycle with our selection of the 48 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.